Unlocking the TRUE POTENTIAL of 340B

SPONSORED CONTENT

Primary care organizations often view themselves as a “Medical Home” for their patients, focusing on resolving patient health problems through their medical services. However, a significant challenge for providers lies in the inability to monitor and influence a patient’s behavior in the time between medical visits. Surprisingly, pharmacy professional services, designed to address

Read More »

Unlocking the Value of 340B Consultants: Their Roles and Responsibilities

SPONSORED CONTENT

In the complex landscape of healthcare, the 340B program plays a vital role in ensuring that vulnerable patients with limited financial resources have access to affordable medications. It enables qualified covered entities to maximize their resources and offer a wider range of benefits and services to those in need.

Managing this program efficiently and

Read More »

3 Things Hospitals and Grantees Need to Know about the Genesis Decision

SPONSORED CONTENT

The much-awaited decision in the Genesis Health Care patient definition case in federal district court in South Carolina provides 340B hospitals and federal grantees welcome re-affirmations of the importance of the vital safety-net care they provide as well as Congress’s intent to support that care through the 340B program. Although the court limited

Read More »

Understanding the Top Five Challenges Facing Health Center Pharmacies Today

Holly Russo headshot

SPONSORED CONTENT

Part 1 of 2: Managing costs and ensuring favorable contracting

As industry veterans know too well, having an in-house pharmacy can be greatly beneficial for both community health centers (CHCs) and their patients. Not only do they offer patient convenience and a greater level

Read More »

Upcoming DIR Fee Changes and Their Potential Impact on 340B Programs

SPONSORED CONTENT

The Centers for Medicare & Medicaid Services (CMS) has issued a final rule that goes into effect on January 1, 2024 that changes the way Direct and Indirect Remuneration (DIR) fees are collected. To understand the impact of this change, let’s review some background on DIR fees:

Read More »

340B…or not to B…?

Robin George headshot

SPONSORED CONTENT

The 340B program, enacted in 1992, enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.

In 2010, the 340B program was expanded under the Affordable Care Act, allowing covered entities to contract with an unlimited number of contract pharmacies such as Walgreens to provide 340B discount

Read More »

4 Ways Hospital Pharmacies Can Unlock Financial Stability

SPONSORED CONTENT

With so many challenges facing health systems today — from 340B contract pharmacy restrictions to drug shortages, labor issues, and ever-rising costs — revenue integrity has become essential to financial stability.

With huge increases in drug expenditures from pre-pandemic levels, health systems must focus on maximizing efficiency, reducing medication costs, and increasing revenue.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report